Nationwide Children's News Releases
Viewing: 41-50 of 96 | All
Dec 01, 2015
Nationwide Children's Hospital Researcher, Mark Peeples, PhD, Elected as AAAS Fellow
Mark Peeples, PhD, principal investigator in the Center for Vaccines and Immunity at Nationwide Children’s Hospital, has been elected a Fellow in the American Association for the Advancement of Science (AAAS). Dr.
Jul 08, 2015
Dr. John Barnard Expands Leadership Role At Nationwide Children's Hospital And The Ohio State University
John A. Barnard, MD, President of The Research Institute at Nationwide Children’s Hospital, has been appointed both Chair of the Department of Pediatrics at The Ohio State University College of Medicine and Chief of Pediatrics at Nationwide Children’s Hospital.
May 07, 2015
Cure SMA Provides Additional Funding for Promising Spinal Muscular Atrophy Research at Nationwide Childrens Hospital
Cure SMA, the leading organization dedicated to the treatment and cure of spinal muscular atrophy (SMA), recently provided an additional $445,000 grant toward a gene therapy for SMA at Nationwide Children’s Hospital.
Apr 03, 2015
Cure Duchenne to Host a Webinar on Duplication Research for Duchenne Muscular Dystrophy with Dr. Kevin Flanigan from Nationwide Childrens Hospital on April 6
NEWPORT BEACH, Calif. -- CureDuchenne, a nonprofit that raises awareness and funds research to find a cure for Duchenne muscular dystrophy, will host an “Update on Duplication Mutation Research for Duchenne Muscular Dystrophy” webinar with Dr.
Aug 11, 2014
Discovery of New Form of Dystrophin Protein Could Lead to Therapy for Some DMD Patients
Scientists have discovered a new form of dystrophin, a protein critical to normal muscle function, and identified the genetic mechanism responsible for its production. Studies of the new protein isoform, published online Aug.
May 27, 2014
Nationwide Childrens Hospital receives $10 million gift from the Nationwide Insurance Foundation establishing the Nationwide Pediatric Innovation Fund
Nationwide Children’s Hospital today announced that it has received a $10 million gift from the Nationwide Insurance Foundation. The gift will establish the Nationwide Pediatric Innovation Fund at Nationwide Children’s Hospital, supporting pediatric research and innovative projects
Mar 26, 2014
Study Identifies Key Player in Motor Neuron Death in Lou Gehrigs Disease
Amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, is marked by a cascade of cellular and inflammatory events that weakens and kills vital motor neurons in the brain and spinal cord. The process is complex, involving cells that ordinarily protect the neurons from harm.
Mar 20, 2014
Parent Project Muscular Dystrophy Awards Nationwide Childrens Hospital; Names Hospital Certified Duchenne Care Center
Nationwide Children’s Hospital was named the first Certified Duchenne Care Center by Parent Project Muscular Dystrophy (PPMD), the leading advocacy organization working to end Duchenne muscular dystrophy (Duchenne).
Dec 03, 2013
Dr. Edwin Horwitz Appointed Director of Blood and Marrow Transplant at Nationwide Childrens Hospital
Edwin M. Horwitz, MD, PhD, recently was appointed director of Blood and Marrow Transplant (BMT) at Nationwide Children’s Hospital. Dr. Horwitz, board-certified in Pediatric Hematology/Oncology, comes to Nationwide Children’s from the Children’s Hospital of Philadelphia (CHOP).
Nov 25, 2013
Two Faculty in The Research Institute at Nationwide Childrens Hospital Named AAAS Fellows
Brian K. Kaspar, PhD, and Veronica J. Vieland, PhD, principal investigators in The Research Institute at Nationwide Children’s Hospital, have been named Fellows of the American Association for the Advancement of Science (AAAS).